Reactions of {4-[bis(2-chloroethyl)amino]phenyl}acetic acid (phenylacetic acid mustard) with 2'-deoxyribonucleosides

被引:0
作者
Florea-Wang, Diana
Ijas, Inna
Hakala, Kristo
Mattinen, Jorma
Vilpo, Juhani
Hovinen, Jari [1 ]
机构
[1] Turku Univ, Dept Chem, FIN-20014 Turku, Finland
[2] Univ Turku, Dept Pharmacol & Clin Pharmacol, Inst Biomed, FIN-20520 Turku, Finland
[3] Abo Akad Univ, Dept Organ Chem, FIN-20500 Turku, Finland
[4] Tampere Univ Hosp, Dept Clin Chem, FIN-33521 Tampere, Finland
[5] Tampere Univ, FIN-33521 Tampere, Finland
[6] PerkinElmer Life & Analyt Sci, FIN-20101 Turku, Finland
关键词
D O I
10.1002/cbdv.200790033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phenylacetic acid mustard (PAM; 2). a major metabolite of the anticancer agent chlorambucil (CLB; 1), was allowed to react with 2'-deoxyadenosine (dA), 2'-deoxyguanosine (dG), 2'-deoxycytidine (dC), 2'-deoxy-5-methylcytidine (dMeC), and thymidine (T) at physiological pH (cacodylic acid, 50% base). The reactions were followed by HPLC and analyzed by HPLC/MS and/or 1H-NMR techniques. Although the predominant reaction observed was hydrolysis of PAM, 2 also reacted with various heteroatoms of the nucleosides to give a series of products: compounds 5-31. PAM (2) was found to be hydrolytically slightly more stable than CLB (1). The principal reaction sites of 2 with dA, dG, and with all pyrimidine nucleosides were N(1), N(7), and N(3), resp. Also. several other adducts were detected and characterized. There was no significant difference in the reactivity of 1 and 2 with dG, dA or T. but the N(3) dC-PAM adduct was cleaminated easier than the corresponding CLB derivativc. The role of PAM-2'-deoxyribonucleoside adducts on the cytotoxic and mutagenic properties of CLB (1) is discussed.
引用
收藏
页码:406 / 423
页数:18
相关论文
共 27 条
[1]  
[Anonymous], 1983, MOL BIOL MUTAGENS CA
[2]   A PHARMACOKINETIC STUDY OF PREDNIMUSTINE AS COMPARED WITH PREDNISOLONE PLUS CHLORAMBUCIL IN CANCER-PATIENTS [J].
BASTHOLT, L ;
JOHANSSON, CJ ;
PFEIFFER, P ;
SVENSSON, L ;
JOHANSSON, SA ;
GUNNARSSON, PO ;
MOURIDSEN, H .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (03) :205-210
[3]  
CHESON BD, 1993, CHRONIC LYMPHOCYTIC
[4]   Alkylation damage in DNA and RNA -: repair mechanisms and medical significance [J].
Drablos, F ;
Feyzi, E ;
Aas, PA ;
Vaagbo, CB ;
Kavli, B ;
Bratlie, MS ;
Peña-Diaz, J ;
Otterlei, M ;
Slupphaug, G ;
Krokan, HE .
DNA REPAIR, 2004, 3 (11) :1389-1407
[5]   CHRONIC LYMPHOCYTIC-LEUKEMIA - AN UPDATED REVIEW [J].
FAGUET, GB .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (09) :1974-1990
[6]   Reactions of N,N-bis(2-chloroethyl)-p-aminophenylbutyric acid (Chlorambucil) with 2′-deoxycytidine, 2′-deoxy-5-methylcytidine, and thymidine [J].
Florea-Wang, D ;
Haapala, E ;
Mattinen, J ;
Hakala, K ;
Vilpo, J ;
Hovinen, J .
CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (03) :383-391
[7]   Reactions of N,N-bis(2-chloroethyl)-p-aminophenylbutyric acid (chlorambucil) with 2′-deoxyadenosine [J].
Florea-Wang, D ;
Haapala, E ;
Mattinen, J ;
Hakala, K ;
Vilpo, J ;
Hovinen, J .
CHEMICAL RESEARCH IN TOXICOLOGY, 2003, 16 (03) :403-408
[8]  
FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, pCH17
[9]  
Fujii T, 1998, HETEROCYCLES, V48, P359
[10]   PHARMACOKINETICS OF CHLORAMBUCIL-TERTIARY BUTYL ESTER, A LIPOPHILIC CHLORAMBUCIL DERIVATIVE THAT ACHIEVES AND MAINTAINS HIGH-CONCENTRATIONS IN BRAIN [J].
GREIG, NH ;
DALY, EM ;
SWEENEY, DJ ;
RAPOPORT, SI .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (05) :320-325